Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”) announced that an abstract was accepted for presentation at the Plenary Session at the American Society of Clinical Oncology (ASCO) ...

Methods: This was a randomised, placebo controlled, double blind, multicentre study in 120 patients with traumatic blunt soft tissue injury. Within 3 h of the injury participants of sport competitions ...

Design Double-blind randomized controlled trial. Setting Free-roaming leisure-time distance runners. Participants Study participants were recruited through newspaper advertisements, posts on ...